Cumberland Pharmaceuticals (CPIX) Total Liabilities (2016 - 2025)
Cumberland Pharmaceuticals (CPIX) has disclosed Total Liabilities for 16 consecutive years, with $52.3 million as the latest value for Q4 2025.
- Quarterly Total Liabilities fell 1.43% to $52.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.3 million through Dec 2025, down 1.43% year-over-year, with the annual reading at $52.3 million for FY2025, 1.43% down from the prior year.
- Total Liabilities hit $52.3 million in Q4 2025 for Cumberland Pharmaceuticals, up from $40.1 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $57.0 million in Q4 2022 to a low of $40.1 million in Q3 2025.
- Historically, Total Liabilities has averaged $49.3 million across 5 years, with a median of $52.3 million in 2022.
- Biggest five-year swings in Total Liabilities: soared 36.06% in 2022 and later decreased 23.43% in 2025.
- Year by year, Total Liabilities stood at $41.9 million in 2021, then soared by 36.06% to $57.0 million in 2022, then fell by 7.79% to $52.5 million in 2023, then increased by 0.99% to $53.0 million in 2024, then dropped by 1.43% to $52.3 million in 2025.
- Business Quant data shows Total Liabilities for CPIX at $52.3 million in Q4 2025, $40.1 million in Q3 2025, and $40.2 million in Q2 2025.